Pandemic H5N1 Influenza
4 clinical trials · Condition
◉ Watch Pandemic H5N1 Influenza
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects (NCT01766921) | Novartis Vaccines | 2013-01-01 |
| Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children (NCT01776554) | Novartis Vaccines | 2013-01-01 |
| Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults (NCT01776541) | Novartis Vaccines | 2013-01-01 |
| Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects (NCT00914771) | Novartis Vaccines | 2009-09-01 |
Track Pandemic H5N1 Influenza automatically
Every clearance here is in the API, with alerts when new ones post.